CEO

2019 5 9

2019 3

• 2019 3 3

•

2017 3 IFRS IFRS

Index1. 2019 3

2. (2017 5 )

3. (2020 3 2022 3 )

4. 2020 3

( )2019 3

3

1. 2019 3

4

2019 3

2,935.0 100% 2,819.3 100% 104.1%

1,318.9 44.9% 1,229.8 43.6% 107.2%

812.3 27.7% 825.4 29.3% 98.4%

195.7 6.7% 167.5 5.9% 116.9%

4.8 0.2% △5.7 △0.2% -

612.8 20.9% 590.7 21.0% 103.7%

412.2 14.0% 392.2 13.9% 105.1%

2019 3

1USD 110.9円 110.9円

1EUR 128.4円 129.7円

1CNY 16.5円 16.8円

2,213

2,526 2,498

2,8192,935

444

607

517

590 612

266

392 406392

412

2015.3 2016.3 2017.3 2018.3 2019.3

IFRS

※

IFRS

− 40.7 1.8

- 105.5% 103.4%

− 15.8 3.1

200.0 158.4

5

2019 3

2,935.0 100.0% 104.1% -

705.1 24.0% 106.3% 106.1%

EMEA 756.7 25.8% 102.4% 103.6%

782.1 26.7% 108.5% 110.1%

AP 250.2 8.5% 102.0% -

440.7 15.0% 97.9% -

43.838.6

73.5 9.8 △9.4 △40.7

2018.3 2019.3

2018 3 2019 3

39.2% 39.5%

6

2,935

2,819

115.7

1,816.9 61.9% 1,748.4 62.0% 103.9% 105.3%

210.7 7.2% 206.2 7.3% 102.2% 104.0%

2,027.6 69.1% 1,954.6 69.3% 103.7% 105.2%

139.2 4.7% 111.9 4.0% 124.4% 126.0%

31.9 1.1% 32.6 1.2% 97.6% 99.0%

479.4 16.3% 450.0 16.0% 106.5% 108.0%

650.6 22.2% 594.6 21.1% 109.4% 110.9%

2,678.2 91.3% 2,549.2 90.4% 105.1% 106.5%

15.3 0.5% 16.1 0.6% 95.5% 97.3%

102.5 3.5% 89.5 3.2% 114.5% 116.1%

0.5 0.0% 0.1 0.0% 371.4% 371.4%

118.4 4.0% 105.8 3.8% 111.9% 113.0%

138.3 4.7% 164.2 5.8% 84.2% 85.6%

2,935.0 100.0% 2,819.3 100.0% 104.1% 105.5%

826.6 28.2% 838.3 29.7% 98.6% 99.8%

1,678.2 57.2% 1,580.7 56.1% 106.2% 107.8%

345.8 11.8% 311.5 11.1% 111.0% 112.1%

84.2 2.9% 88.6 3.1% 95.0% 96.7%

2019 3

※1※2 2019 3 2Q 2019 3 3Q

7

22

• 88

•

5.2

•

1.3

•

28 6.7

•

Partec

10.7

16.6

590.7

612.8

88.2

10.21.8

△55.3

5.2

△28.2

2018.3 2019.3

+22.0 (103.7%)

8

3,219

3,467 △103.8

116.7△7.4

99.1

86.6

32.723.9

2018.3 2019.3

247.9

104.7

143.2

3,219

3,467

4.5 6.0

264.9

2018.3 2019.3

10.5

237.3

27.5

247.9

9

328.3

△ 194.0

△ 108.6

14.6

522.4

△ 378.2

△ 115.4

35.0

447.4

△ 401.2

△ 140.9△ 103.8

2017.3 2018.3 2019.3

10

11

CN-6000/CN-3000

XS

Caresphere

XN-31 CE

Sysmex Partec CyFlow Counter System WHO

OSNA RD-200 CK19

Todai OncoPanel

OncoGuide NCC

LW-100

1 HM-1000

HDL

FISH MI-1000

R&D

3

シスメックス エジプト

Automated Hematology Analyzer XN-31

495

592 601663

705

2015.3 2016.3 2017.3 2018.3 2019.3

2019 3

( ) ( )

705.1 663.5 106.3% 106.1%

245.7 227.6 107.9% 107.6%

292.3 274.8 106.4% 106.2%

167.1 161.0 103.8% 103.6%

Mill

ion

USD

IFRS

IFRS

CLIA Waived XW-100 4

450.8493.3

555.4599.5

635.9

2015.3 2016.3 2017.3 2018.3 2019.3

12

売上高

EMEA

635682

646

739 756

2015.3 2016.3 2017.3 2018.3 2019.3

OSNA RD-210

2019 3

( ) ( )

756.7 739.2 102.4% 103.6%

221.4 214.8 103.1% 104.4%

418.4 409.7 102.1% 103.3%

116.8 114.6 102.0% 103.1%

458.3514.5

544.0569.3 590.0

2015.3 2016.3 2017.3 2018.3 2019.3

Mill

ion

EU

R

IFRS

IFRS

13

売上高

2 CRP

XS-500ix

498

651603

720782

2015.3 2016.3 2017.3 2018.3 2019.3

2,803

3,458

3,745

4,301 4,736

2015.3 2016.3 2017.3 2018.3 2019.3

Mill

ion

CN

Y

IFRS

IFRS

14

2019 3

( ) ( )

782.1 720.8 108.5% 110.1%

199.9 212.5 94.1% 95.0%

531.9 482.9 110.1% 112.0%

50.2 25.4 197.4% 201.8%

売上高

※

※ 2019 3 3Q

※

AP

IFRS

4

2019 3

( )

250.2 245.4 102.0%

68.5 77.5 88.3%

158.4 146.3 108.2%

23.3 21.4 108.6%178

201

212

245250

2015.3 2016.3 2017.3 2018.3 2019.3

15

売上高

NCC 12

CN

2019 3

( )

440.7 450.1 97.9%

91.0 105.7 86.0%

277.0 266.6 103.9%

72.5 77.7 93.4%

IFRS

405 398

434450 440

2015.3 2016.3 2017.3 2018.3 2019.3

16

売上高

2014 3 4 3

– Inostics OncoBEAM

– Partec FCM 2020 3

– NCC 2020 3

– OGT FISH （億円）

2019 3 2018 3前年同期比

Inostics15.2 18.2 △3.0

△9.1 △14.4 +5.3

Partec20.4 15.6 +4.8

△1.7 △6.7 +5.0

22.5 18.8 +3.7

△1.4 △3.7 +2.3

OGT※37.1 25.4 +11.7

6.1 2.8 +3.3

※Oxford Gene Technology 2017 717

中間 期末 年間 配当性向

2018年3月期 30 円 36円 66円 35.1 %

2019年3月期

（案）34円 36円 70円 35.4 %

※ 50 6※※ 52

※※

18

2018 3 4

2

※

19

2019 3

659.5 625.5 105.4% 105.3%

35.8 55.3 64.7％ 64.4％

EMEA776.0 755.4 102.7% 104.0%

70.9 49.7 142.6％ 144.0％

781.1 720.1 108.5% 110.1%

91.2 83.2 109.6％ 110.6％

AP247.5 244.0 101.4% -

31.1 31.6 98.3％ -

※470.7 474.1 99.3% -

389.9 378.5 103.0％ -

※IDEXX

2. (2017 5 )

20

1

2019 3

2,819

2,935

2,750

3,100

3,500

2018.3 2019.3 2020.3

591

570

612620

720

2019 3

•

−

−

−

−

− FCM

−

−

※

• 20

21

(20.0%)(20.9%)

(20.7%)(21.0%)

※※

2

IT

FCM

•

− FCM

− NCC

− HM-1000 HI-1000

MI-1000, PCR LW-100

•

22

3.(2020 3 2022 3 )

23

AI

24

IVD-R

2,819 2,935 3,200

3,800

2018.3 2019.3 2020.3 2022.3

590

1. IVD

2.

3. /

4. /

5.

6.

FCM

NCC

2025

IVD

25

売上

営業利益

【2022 3

3,800

780 20.5

ROE 18.0

CF 400

CF 750612

640

780

IVD 1

26

IVD

• IVD

•

• IVD

1,816

2,160

479

615210

255

139

255

31

35

15

80

141

140

2,831

2019.3

3,540

2022.3

708CAGR 7.7

FCM

•

− Caresphere

−

− XW-100

•

− 2

−

−

IVD 2

27

• CN No.1

•

• UN

• HISCL

•

FCM

• FCM

•

1,816

2,160

479

615210

255

139

255

31

35

15

80

141

140

2,831

2019.3

3,540

2022.3

FCM

708CAGR 7.7

103

2019.3

260

2022.3

156CAGR 35.9 • OSNA

−

− RD-210 EMEA

−

• OGT FISH

− FISH

− FISH

•

− NCC

•

− OncoBEAM RAS IVD PSS LDT※

− HISCL

− CTC LDT

28※LDT Laboratory Developed Test

• 2019 4

FCM

IVD

LS

29

•

•

− IVD

−

− R&D

Quality Management System (QMS)

30

•

•

IT

Caresphere

Sysmex

31

3

&

IVD

( )

IT

M&A

IVD

IVDFCM

30

32

33

CSR

CSR KPI

CSR

CO2

CO2

• KPI

4. 2020 3

34

2,8192,935

3,200

590 612 640

392 412420

2018.3 2019.3 2020.3

2020 3

3,200 640 20.0%

420 13.1%

140 240 220( )

USD 6.3億円 7.0億円

EUR 4.5億円 1.1億円

CNY 52.3億円 4.1億円

(19 3 )

1 USD 110.0円 110.9円

1 EUR 125.0円 128.4円

1 CNY 16.5円 16.5円

(9.0% )

1.9% )

4.4% )

35

(IFRS16適用によるリース会計基準の変更含む）

3.125 3.75 5 6.59

12 12.5 14 15 17 20

27

38

52

58

6670 72

18.9%22.6%

17.8% 17.9% 20.0%

26.8%31.9% 29.4% 27.0% 29.1% 29.1% 27.1% 29.6% 27.5% 29.7%

35.1% 35.4% 35.8%

0

10

20

30

40

50

60

70

80

03.3 04.3 05.3 06.3 07.3 08.3 09.3 10.3 11.3 12.3 13.3 14.3 15.3 16.3 17.3 18.3 19.3 20.3

2014 4 1 (

( )

※2005 11 18 1:2※2011 4 1 1:2※2014 4 1 1:2

18 (2020 3 )

30%

( )

2016 3 IFRS

36

( ) 2019 3

37

590.7 612.8 103.7%

△1.8

△8.2

＋10.7

OGT △0.6

IFRS15 △1.9

△16.6

576.6 608.4 105.5%

2,819.3 2,935.0 104.1%

＋40.7

△15.4

OGT △8.8

IFRS15 △1.9

△3.9

2,803.9 2,961.0 105.6%

※2

※1

( )

392.2 412.2 105.1%

△1.2

△14.3

＋10.7

OGT △0.5

IFRS15 △1.5

△11.8

＋7.5

△3.5

384.3 405.3 105.3%

※1 2017 10

+8.4

※2 2017 6

※1

※1

38

( )

39

40

2019 32020 3 2022 3

CAGR(3 )

1,816 1,926 + 6.0% 2,160 +5.9%

479 519 +8.2% 615 +8.7%

210 224 +6.3% 255 +6.6%

139 167 +20.0% 255 +22.4%

31 32 +0.3% 35 +3.1%

FCM※ 15 30 +95.0% 80 +73.3%

137 132 - 140 -

IVD 2,831 3,030 +7.0% 3,540 +7.7%

103 170 +64.1% 260 +35.9%

2,935 3,200 +9.0% 3,800 +9.0%

※2020 3 IVD

41

2019 3 2020 3 2022 3

CAGR(3 )

705 767 +8.8% 896 +8.3%

EMEA 756 804 +6.2% 935 +7.3%

782 871 +11.4% 1,087 +11.6%

AP 250 276 +10.3% 352 +12.0%

440 482 +9.4% 530 +6.3%

2,935 3,200 +9.0% 3,800 +9.0%

2019 32020 3 2022 3

CAGR(3 )

635 697 +9.7％ 814 +8.6%

EMEA 590 643 +9.0％ 748 +8.2%

4,736 5,278 +11.5% 6,587 +11.6%

USD EUR CNY

110.0円 125.0円 16.5円

PL

42

2019 3 2020 3 2022 3

659 716 824

35 38 44

EMEA776 828 977

70 71 85

781 871 1,087

91 87 103

AP247 274 350

31 31 40

470 511 562

1,078 1,171 1,409

1,549 1,682 1,971

389 415 510